| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00109-010-0641-2 |
| P698 | PubMed publication ID | 20563546 |
| P50 | author | Massimo Volpe | Q37829227 |
| Speranza Donatella Rubattu | Q42806790 | ||
| Sebastiano Sciarretta | Q47782078 | ||
| Camilla Calvieri | Q57057547 | ||
| Allegra Battistoni | Q91610769 | ||
| P2093 | author name string | Angelica Morriello | |
| P2860 | cites work | Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux | Q24533528 |
| A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation | Q24648813 | ||
| Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype | Q28188327 | ||
| Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide | Q28208582 | ||
| A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse | Q28235995 | ||
| Variable number of tandem repeat of the 5'-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension | Q28241358 | ||
| Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans | Q28250065 | ||
| Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure | Q28250251 | ||
| Natriuretic peptide receptor-C signaling and regulation | Q28252424 | ||
| Arterial stiffness, physical activity, and atrial natriuretic Peptide gene polymorphism in older subjects | Q28287447 | ||
| The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system | Q28506517 | ||
| Impairment of the natriuretic peptide system in follitropin receptor knockout mice and reversal by estradiol: implications for obesity-associated hypertension in menopause | Q28512933 | ||
| Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. | Q28569799 | ||
| The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging | Q28571552 | ||
| Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide | Q28577335 | ||
| Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells | Q28580000 | ||
| Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor | Q28582616 | ||
| Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA. | Q33940389 | ||
| Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure | Q34207430 | ||
| A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats | Q34281894 | ||
| Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET | Q35540268 | ||
| Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice | Q35600561 | ||
| Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). | Q35619698 | ||
| Cloning of a cDNA encoding porcine brain natriuretic peptide. | Q35991271 | ||
| Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. | Q37157505 | ||
| Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs | Q37693870 | ||
| Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells | Q38347381 | ||
| Sequencing and cardiac expression of natriuretic peptide receptors A and C in normal and heart failure pigs | Q39899090 | ||
| Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice | Q39941121 | ||
| Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways | Q40241686 | ||
| Natriuretic peptide C-receptor: more than a clearance receptor | Q40709502 | ||
| Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase | Q40891941 | ||
| Atrial natriuretic peptide-C receptor and membrane signalling in hypertension | Q41583151 | ||
| Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system | Q41733809 | ||
| Depletion of natriuretic peptide C receptors eliminates inhibitory effects of C-type natriuretic peptide on evoked neurotransmitter efflux. | Q42489814 | ||
| ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity | Q42505057 | ||
| Pertussis toxin attenuates atrial natriuretic factor-mediated inhibition of adenylate cyclase. Involvement of inhibitory guanine nucleotide regulatory protein | Q42509639 | ||
| Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy. | Q43068711 | ||
| Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats | Q43270603 | ||
| Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro. | Q43287306 | ||
| Inhibition of cyclooxygenase-2 by natriuretic peptides | Q43893277 | ||
| Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor. | Q44712594 | ||
| Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity | Q44774949 | ||
| Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure | Q45107577 | ||
| Natriuretic peptides inhibit rat astroglial proliferation: mediation by C receptor | Q46167103 | ||
| cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells | Q46293559 | ||
| C-Type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention. | Q46614856 | ||
| Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation | Q46755401 | ||
| Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy | Q46792345 | ||
| Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides | Q47711213 | ||
| Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. | Q48141286 | ||
| C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling | Q48318699 | ||
| BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors | Q48417679 | ||
| Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. | Q48451379 | ||
| Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. | Q48459991 | ||
| Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells | Q48474418 | ||
| Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats | Q48578164 | ||
| Human coronary atherosclerosis modulates cardiac natriuretic peptide release. | Q48730177 | ||
| Gene expression of natriuretic peptides and their receptors type-A and -C after myocardial infarction in rats. | Q48882919 | ||
| Expression of natriuretic peptide receptors in human adipose and other tissues | Q48895756 | ||
| C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain | Q49017266 | ||
| Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes. | Q50627677 | ||
| Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. | Q51565127 | ||
| Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. | Q51571442 | ||
| Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue. | Q51584646 | ||
| Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. | Q51760265 | ||
| Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. | Q52170953 | ||
| G-proteins and adenylyl cyclase signalling in hypertension. | Q52201998 | ||
| Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats. | Q52526767 | ||
| Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction. | Q53499842 | ||
| Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells | Q67881112 | ||
| Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells | Q69331732 | ||
| Physiological role of silent receptors of atrial natriuretic factor | Q69810517 | ||
| Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells | Q70146241 | ||
| C‐type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF‐R2/ANP‐C receptors | Q71994793 | ||
| Localization of atrial natriuretic factor receptors in the mesenteric arterial bed. Comparison with angiotensin II and endothelin receptors | Q72331319 | ||
| Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues | Q72364400 | ||
| A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives | Q72996635 | ||
| The gene encoding atrial natriuretic peptide and the risk of human stroke | Q73092438 | ||
| Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat | Q73175866 | ||
| An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair | Q73519920 | ||
| Natriuretic peptides | Q74817622 | ||
| Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway | Q75217684 | ||
| Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease | Q78754385 | ||
| Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification | Q81937242 | ||
| Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide | Q83378282 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 889-897 | |
| P577 | publication date | 2010-06-19 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | NPR-C: a component of the natriuretic peptide family with implications in human diseases | |
| P478 | volume | 88 |
| Q91610774 | ARNi: A Novel Approach to Counteract Cardiovascular Diseases |
| Q88012455 | Aberrant pro-atrial natriuretic peptide/corin/natriuretic peptide receptor signaling is present in maternal vascular endothelium in preeclampsia |
| Q48531972 | Association of natriuretic peptide receptor-C gene with ischemic stroke and hypertension in Chinese Han population |
| Q38194620 | Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases |
| Q82388207 | Biomarkers in the Management of Heart Failure |
| Q33812913 | C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP. |
| Q92528676 | Cardiovascular Pleiotropic Effects of Natriuretic Peptides |
| Q42958302 | Characterization of two ENU-induced mutations affecting mouse skeletal morphology |
| Q38211377 | Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors. |
| Q58318917 | Isolation and Characterization of a Natriuretic Peptide from Crotalus oreganus abyssus (Grand Canyon Rattlesnake) and its Effects on Systemic Blood Pressure and Nitrite Levels |
| Q37963837 | M-atrial natriuretic peptide: a novel antihypertensive protein therapy. |
| Q37914058 | Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. |
| Q37262907 | NPR3 protects cardiomyocytes from apoptosis through inhibition of cytosolic BRCA1 and TNF-α. |
| Q36625683 | Nanoparticle PET/CT imaging of natriuretic peptide clearance receptor in prostate cancer |
| Q41672035 | Natriuretic Peptide Receptor-C is Up-Regulated in the Intima of Advanced Carotid Artery Atherosclerosis. |
| Q26827702 | Natriuretic Peptides and Cardiometabolic Health |
| Q89442819 | Natriuretic Peptides and Normal Body Fluid Regulation |
| Q38371173 | Natriuretic Peptides as a Novel Target in Resistant Hypertension |
| Q36936568 | Natriuretic peptide receptor-3 gene (NPR3): nonsynonymous polymorphism results in significant reduction in protein expression because of accelerated degradation |
| Q38162429 | Natriuretic peptides in cardiovascular diseases: current use and perspectives |
| Q92991075 | Pulmonary Arterial Hypertension Due to NPR-C Mutation: A Novel Paradigm for Normal and Pathologic Remodeling? |
| Q38261513 | Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure |
| Q37231706 | Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney. |
| Q34938248 | Role of musclin in the pathogenesis of hypertension in rat |
| Q47855200 | Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure |
| Q51623809 | Systemic, but not cardiomyocyte-specific, deletion of the natriuretic peptide receptor guanylyl cyclase A increases cardiomyocyte number in neonatal mice. |
| Q50055077 | T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients. |
| Q50034119 | The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases |
Search more.